The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
This preferential treatment harms independent pharmacies and ... there has traditionally been a lack of uptake in biosimilars on PBM formularies, likely due to less favorable PBM rebate models ...
The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
Based on conversations with industry expects, the Act, while incremental, does not include any adverse new ideas that would materially harm PBM profits, and the text allows enough room and time ...
Ron Wyden says Elon Musk, an advisor to President Donald Trump who's on track to lead a new Department of Government Efficiency, pushed the PBM provisions out of the package. The new American ...
The PBM changes would put guardrails on the business practices of the industry, something that’s been a bipartisan priority for years but, until now, never made it to the finish. The package ...
The clock is ticking on a lame duck Congress. Pharmacy benefit manager reform is essential | Opinion
And some patients have even died because they couldn’t access affordable treatment. The complaint ... have voted overwhelmingly in favor of PBM transparency and reforms. Here in New Jersey ...
"They're helping patients kind of manage through the treatment paradigm with respect to which drugs to take, which formulary drugs are on, and kind of managing that whole process. So there is a ...
Our cutting edge treatment modalities bring hope and relief ... and Photobiomodulation (PBM). If you are living with mental illness and wish to be evaluated as a candidate for our treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback